Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Recruiting
60 enrolled
Pre-malignant States to Hematologic Malignancies in Firefighters
Recruiting
300 enrolled
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
Active not recruiting
1,836 enrolled
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
Completed
1,340 enrolled
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Recruiting
1,000 enrolled
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
Enrolling by invitation
120 enrolled
HTLV-OBS
Active not recruiting
69 enrolled
CHIS
Not yet recruiting
5,000 enrolled
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
Not yet recruiting
400 enrolled
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Recruiting
88 enrolled
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recruiting
30 enrolled
Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers
Active not recruiting
192 enrolled
NICHE
Recruiting
2,300 enrolled
CVE-CART
Completed
44 enrolled
Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
Recruiting
20 enrolled
CS22-03
Completed
30 enrolled
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Recruiting
500 enrolled
CAMPERR
Recruiting
7,000 enrolled
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Active not recruiting
992 enrolled
Bone Marrow Grafting for Leukemia and Lymphoma
Enrolling by invitation
9,999 enrolled
QOL-ONE PRO-CT
Not yet recruiting
162 enrolled
VeRVe
Recruiting
500 enrolled
GMALLregistry
Recruiting
10,000 enrolled
EPOCH
Recruiting
45 enrolled
LIBERATE
Recruiting
2,500 enrolled
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Recruiting
100 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
Recruiting
40 enrolled
REBOUND
Completed
126 enrolled
YASU Research Registry: For Young Adults With Cancer
Terminated
192 enrolled
HALO-SCT
Recruiting
1,000 enrolled
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Recruiting
500 enrolled
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
Completed
11 enrolled
succinylation
Not yet recruiting
200 enrolled
CR3C
Recruiting
300 enrolled
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
CarChem
Active not recruiting
169 enrolled
Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy
Recruiting
24 enrolled
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Recruiting
420 enrolled
Early Ageing During Therapy in AYA Cancer Patients
Recruiting
120 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
Collecting and Storing Tissue From Young Patients With Cancer
Completed
213 enrolled
REDEFINE
Recruiting
130 enrolled
LeukemiaCort
Recruiting
40 enrolled
Blood Samples to Identify Biomarkers of Busulfan
Terminated
139 enrolled
FUTURE
Not yet recruiting
640 enrolled
MOHCCN-O
Recruiting
500 enrolled
Circulating microRNAs as Disease Markers in Pediatric Cancers
Completed
20 enrolled
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy
Recruiting
321 enrolled